Evidence map›Paper›PMID 24331194›Full record

ReviewSeminars in oncology2013

Energy balance and metabolism after cancer treatment.

Emily S Tonorezos, Lee W Jones

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Metabolomics in oncology.Cancer reports (Hoboken, N.J.) · 2023
    Review
  15. Review
  16. Review
  17. Article
  18. Preventive Cardio-Oncology: The Time Has Come.Frontiers in cardiovascular medicine · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Emily S TonorezosWeill Cornell Medical College and Memorial Sloan-Kettering Cancer Center, New York NY. Electronic address: tonoreze@mskcc.org.
Lee W JonesDuke Cancer Institute, Durham, NC.
Cornell University · USDuke Cancer Institute

Funding

Randomized Trial of Optimal Type of Aerobic Training in Breast CancerR01CA142566 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI JONES, LEE W · 2010 to 2017
$2.7M
Phase III Trial of Exercise Training in Postsurgical Lung CancerR01CA138624 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI JONES, LEE W · 2009 to 2013
$2.1M
Phase II Trial of Aerobic Training in Metastatic Breast CancerR21CA143254 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI JONES, LEE W · 2010 to 2012
$536k
Exercise Training, Erectile Dysfunction, and Prostate CancerR21CA133895 · NCI · DUKE UNIVERSITY · PI JONES, LEE W · 2009 to 2011
$503k
NCI NIH HHS CA133895NCI NIH HHS CA138624NCI NIH HHS CA142566NCI NIH HHS CA143254NCI NIH HHS R01 CA138624NCI NIH HHS R01 CA142566NCI NIH HHS R21 CA133895NCI NIH HHS R21 CA143254
6 · The paper itself

Abstract

Unfavorable physiological, biological, and behavioral alterations during and following treatment for cancer may lead to chronic energy imbalance predisposing to a myriad of deleterious health conditions including obesity, dyslipidemia, and the metabolic syndrome. In addition to the cardiovascular and musculoskeletal effects of these conditions, energy imbalance and metabolic changes after cancer treatment can also affect cancer-related morbidity and mortality. To this end, lifestyle interventions such as diet and physical activity are especially relevant to mitigate the deleterious impact of chronic energy imbalance in cancer survivors.

Indexed as

Energy MetabolismAntineoplastic AgentsCardiovascular DiseasesDietDyslipidemiasExerciseHumansLife StyleMetabolic SyndromeNeoplasmsObesityRadiotherapyRisk FactorsStem Cell TransplantationAntineoplastic Agents

Identifiers

PMID24331194
PMCPMC3867745
OpenAlexW2008960364

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.